2004
DOI: 10.1128/aac.48.6.2132-2139.2004
|View full text |Cite
|
Sign up to set email alerts
|

Interaction of Antimycobacterial Drugs with the Anti-Mycobacterium aviumComplex Effects of Antimicrobial Effectors, Reactive Oxygen Intermediates, Reactive Nitrogen Intermediates, and Free Fatty Acids Produced by Macrophages

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0
1

Year Published

2011
2011
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(5 citation statements)
references
References 35 publications
0
4
0
1
Order By: Relevance
“…Resident macrophages have some capacity to undergo a respiratory burst, but immunologic activation of macrophages substantially augments this process [ 14 ]. The antimicrobial activity of ROIs has been demonstrated by a variety of approaches and has been most strongly implicated in host defenses against intracellular pathogens such as Listeria monocytogenes , Mycobacterium avium and Francisella tularensis [ 15 18 ]. Infection with L .…”
Section: Introductionmentioning
confidence: 99%
“…Resident macrophages have some capacity to undergo a respiratory burst, but immunologic activation of macrophages substantially augments this process [ 14 ]. The antimicrobial activity of ROIs has been demonstrated by a variety of approaches and has been most strongly implicated in host defenses against intracellular pathogens such as Listeria monocytogenes , Mycobacterium avium and Francisella tularensis [ 15 18 ]. Infection with L .…”
Section: Introductionmentioning
confidence: 99%
“…Oxidative stress in the hepatocyte results in altered mitochondrial permeability and induces apoptosis[4]. Therefore, antioxidants could serve as possible drugs against INH- and RIF-induced hepatic toxic injury[5,6]. …”
Section: Introductionmentioning
confidence: 99%
“…Currently, new CFZ analogs are being tested for treatment of Mycobacterium avium infections associated with AIDS and for multidrugresistant tuberculosis (3)(4)(5)(6). Although primarily antimycobacterial, experimental evidence suggests a broader based activity toward Gram-positive bacteria (7,8) and strains of yeast (9).…”
mentioning
confidence: 99%